Production of vascular endothelial growth factor in T-cell prolymphocytic leukemia

Leukemia Research

Volumn 31, Issue 3, 2007, Pages 403-406

  Ogasawara, Toshie ^a   Narita, Chisako ^a   Kawauchi, Kiyotaka ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Prolymphocytic leukemia; T cell; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

AGED; ARTICLE; BLOOD; BONE MARROW; CASE REPORT; CD25+ T LYMPHOCYTE; CD3 T CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPHENOTYPING; LEUKEMIA CELL; MALE; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; T CELL LEUKEMIA; T LYMPHOCYTE;

AGED; FATAL OUTCOME; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, PROLYMPHOCYTIC; LEUKEMIA, T-CELL; MALE; PLEURAL EFFUSION, MALIGNANT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846097318     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.02.029     Document Type: Article

References (16)

1. Bennet J.M., Catovsky D., Daniel M.-T., Flandrin G., Galton D.A.G., Gralnick H.R., et al. The French-American-British (FAB) Cooperative Group: proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 42 (1989) 567-584
2. Jaffe E.S., Harris N., Stein H., and Vardiman J.W. Tumours of hematopoietic and lymphoid tissues. World Health Organization Classification of Tumours (2001), IRAC Press, Lyon, France
3. Morton L.M., Wang S.S., Devesa S.S., Hartge P., Weisenburger D.D., and Linet M.S. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107 (2006) 265-276
4. Matutes E., Brito-Babapulle V., Swansbury J., Ellis J., Morilla R., Dearden C., et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78 (1991) 3269-3274
5. Herling M., Khouly J.D., Washington L.T., Duvic M., Keating M.J., and Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 104 (2004) 328-335
6. List A.F. Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. The Oncologist 6 (2001) 24-31
7. Weis S.M., and Cheresh D.A. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437 (2005) 497-504
8. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., and Leung D.W. The vascular endothelial growth factor family; identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5 (1991) 1806-1814
9. Park J.E., Keller G.A., and Ferrara N. The vascular endothelial growth factor (VEGF) isoforms; differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular bound VEGF. Mol Biol Cell 4 (1993) 1317-1326
10. Ogawa S., Oku A., Sawano A., Yamaguchi Y., Yazaki Y., and Shibuya M. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries potent mitotic activity without heparin-binding domain. J Biol Chem 273 (1998) 31273-31282
11. Mangi M., and Newland A. Angiogenesis and angiogenic mediators in hematological malignancies. Br J Haematol 111 (2000) 43-51
12. Molica S., Vitelli G., Levato D., Gandorfo G.M., and Liso V. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukemia. Br J Haematol 107 (1999) 605-610
13. Bazarbachi A., Merhi R.A., Gessain A., Tolhouk R., El-Koury H., Nasr R., et al. Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism. Cancer Res 64 (2004) 2039-2046
14. Gear R.B., Heffelfinger S., and Flessa H.C. Unusual lymphoma manifestations. J Clin Oncol 22 (2004) 557-558
15. Fiedler W., Graeven U., and Ergun S. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89 (1997) 1870-1875
16. Bellamy W.T., Richter L., Frutiger Y., and Grogan T.M. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 59 (1999) 728-733